Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray KK, Nicholls SJ, Li N, et al.
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.
Leggi
Breaking news
Use of voice-based conversational artificial intelligence for basal insulin prescription management among patients with type 2 diabetes: a randomized clinical trial
Nayak A, Vakili S, Nayak K, et al.
JAMA Netw Open. 2023;6(12):e2340232.
Leggi
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
Corpeleijn WE, de Waal WJ, Schipper HS, Wiegman A
Diabetologia. Pub. online 30 Nov 2023.
Leggi
The association between glycemic index, glycemic load and total carbohydrate intake and risk of premature coronary artery disease: Iran Premature Coronary Artery: disease study (IPAD): a case-control study
Nurizadeh F, Mohamadifard N, Nouri F, et al.
Nutrition, Metabolism and Cardiovascular Diseases. Pub. online 27 Nov 2023.
Leggi
Obesity management in adults: a review
Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al.
JAMA. 2023;330(20):2000-2015.
Leggi
High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study
Farrell CM, McNeilly AD, Hapca S, et al.
Diabetologia. Pub. online 27 Nov 2023.
Leggi
Sex‐specific associations between skeletal muscle mass and incident diabetes: A population‐based cohort study
Liu D, Li N, Zhou Y, et al.
Diabetes Obes Metab. Pub. online 23 Nov 2023.
Leggi
Sodium‐glucose co‐transporter‐2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes
Fujita KK, Ye F, Collister D, et al.
Diabetes Obes Metab. Pub. online 23 Nov 2023.
Leggi
Euglycemic ketoacidosis in two patients without diabetes after introduction of sodium–glucose cotransporter 2 inhibitor for heart failure with reduced ejection fraction
Umapathysivam MM, Gunton J, Stranks SN, Jesudason D
Diabetes Care. 2023;dc231163.
Leggi
Highlights from AHA 2023—New risk calculator, semaglutide and CVD, and more
Abbasi J
JAMA. Pub. online 22 Nov 2023.
Leggi